You are reading a single comment by @Alan_tbt and its replies.
Click here to read the full conversation.
London Fixed Gear and Single-Speed is a community of predominantly fixed gear and single-speed cyclists in and around London, UK.
This site is supported almost exclusively by donations. Please consider donating a small amount regularly.
branwen
Howard
@Alan_tbt
This taken directly from the BBC live feed today...
Trump 'has stake in anti-Malaria drug'
Hydroxychloroquine. Chances are you only heard that word recently. And there's an even higher chance you heard it because it was mentioned by US President Donald Trump.
Trump has been pushing the drug - a known anti-malarial drug - as the treatment for the virus, encouraging patients to take it, saying: "What do you have to lose?"
Perhaps the real question is - what does Trump have to gain? Quite a bit, says a report by the New York Times.
The report suggests that Trump himself has a "small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine".
The report also suggests that several other pharmaceutical companies also stand to profit - including those with shareholders that have connections to Trump.
But one doctor believes there are more noble reasons for the president's interest.
"I understand why [he's] pushing it. He has to project hope," said Dr Joshua Rosenberg of the Brooklyn Hospital Centre. "Even if there isn't a lot of science behind it, beccause it is at this point, the best, most available option for use."